Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial (Q39383888)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial |
scientific article |
Statements
1 reference
Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial (English)
1 reference
1 reference
Stein Kaasa
1 reference
Stein Sundstrøm
1 reference
Roy Bremnes
1 reference
Ulf Aasebø
1 reference
Steinar Aamdal
1 reference
Reidulv Hatlevoll
1 reference
Paal Brunsvig
1 reference
Dag Clement Johannessen
1 reference
Olbjørn Klepp
1 reference
1 March 2004
1 reference
1 reference
22
1 reference
5
1 reference
801-810
1 reference
Identifiers
1 reference
1 reference